X0306 4 2014-06-23 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001502213 Chai-Onn Robert Roswell 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8 QUEBEC, CANADA 0 1 0 0 EVP, Gen. Couns. & Corp. Secy. Common Stock, no par value 2014-06-23 4 M 0 10203 6.45 A 34202 D Common Stock, no par values 2014-06-23 4 S 0 10203 121.6971 D 23999 D Non-Qualified Stock Options (right to purchase) 6.45 2014-06-23 4 M 0 10203 0 D 2008-08-09 2014-08-09 Common Shares, no par value 10203 0 D This number represents options exercised and sold pursuant to a 10b5-1 trading plan covering these options, which were to expire on August 9, 2014. This number represents the weighted average sale price for all sales of common stock sold by the reporting officer pursuant to a 10b5-1 trading plan. Actual sale executions were in the range of $121.51 and $121.95. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. The options vested one-fourth per year over four years starting from the date of grant with the first vest date falling on the first anniversary of the grant, the second vest date falling on the second anniversary of the grant, the third vest date falling on the third anniversary of the grant, and the fourth vest date falling fourth anniversary of the grant. by: Nicholas Zanoni for Robert Chai-Onn 2014-06-24